Hyperspectral technology for assessing and treating diabetic foot and tissue disease

Patent metadata

Field	Value
Publication number	US-10028676-B2
Application number	US-201514602204-A
Country	US
Kind code	B2
Filing date	Jan 21, 2015
Priority date	Apr 4, 2005
Publication date	Jul 24, 2018
Grant date	Jul 24, 2018

Abstract

This invention relates generally to an index map comprising both pressure and perfusion information from a diabetic patient foot for the purpose of treatment. The index map may also be a map of perfusion and/or metabolism of the tissue (reflecting oxygen delivery and oxygen extraction, obtained by thermal imaging, hyperspectral imaging, or duplex ultrasound, MRA, CT or laser Doppler imaging. This information aids treatment in prevention of diabetic foot ulceration and amputation and in treatment of tissue compromise to prevent tissue loss in other body regions.

First claim

The invention claimed is:

1. A method comprising:
(A) determining a physiological state of a tissue of a subject by using a hyperspectral imaging device to collect tissue oxygenation, tissue oxygen extraction, tissue metabolism, or tissue perfusion information of said tissue;
(B) determining a pressure applied to said tissue;
(C) identifying an area of the tissue at risk for disease formation or disease progression based on the physiological state of the tissue or corresponding aspects of the pressure applied to the tissue; and
(D) modifying the pressure applied to the at risk tissue,
wherein identifying an area of the tissue at risk for disease formation or disease progression includes comparing changes in oxygenation levels of the tissue over a period of time.

2. The method of claim 1 , wherein the tissue is located on a toe, a foot, a leg, a finger, a hand, or an arm of the subject.

3. The method of claim 1 , wherein the pressure applied to the tissue comprises pressure exerted on the tissue from a prosthetic device.

4. The method of claim 3 , wherein the prosthetic device is selected from the group consisting of a toe, foot, hand, finger, leg or arm prosthesis.

5. The method of claim 1 , wherein modifying the pressure applied to the at risk tissue comprises altering the structure of a prosthetic device, a compression stocking, a bandage, or a tissue wrap applied to the subject.

6. The method of claim 5 , wherein altering the structure of the prosthetic device comprises adding or removing cushioning material.

7. The method of claim 6 , wherein the adding or removing cushioning prevents ulceration or tissue breakdown attributable to the prosthetic device.

8. The method of claim 5 , wherein modifying the pressure applied to the at risk tissue reduces the risk of tissue ischemia in unbroken skin, formation of an ulcer or wound, formation of a plantar ulcer, venous stasis, venous ulcer disease, or an infection.

9. The method of claim 1 , wherein the determined pressure applied to said tissue is distributed on tissue of a lower extremity of the subject by a device tailored to increase pressure on tissues around areas of venous ulceration.

10. The method of claim 1 , wherein the determined pressure applied to said tissue is distributed on a foot of the subject by a device tailored to reduce pressure on a wound or area of tissue identified as at risk for disease formation or disease progression to less than zero.

11. The method of claim 1 , wherein:
determining a pressure applied to said tissue includes generating a pressure gradient map that indicates pressures across the sole of a foot of the subject; and
modifying the pressure applied to the at risk tissue includes redistributing pressures across the sole to reduce pressure on areas identified as at risk for disease formation or disease progression.

12. The method of claim 1 , wherein:
determining a pressure applied to said tissue includes generating a pressure gradient map that indicates pressures across the tissue; and
modifying the pressure applied to the at risk tissue includes redistributing pressure across the tissue to reduce pressure on areas identified as at risk for disease formation or disease progression.

13. The method of claim 1 , wherein identifying an area of the tissue at risk for disease formation or disease progression includes comparing an oxygenation map of the tissue generated from the collected tissue oxygenation information to a map of oxygenation levels generated from tissue oxygenation information gathered from tissue of a plurality of subjects.

14. The method of claim 1 , wherein identifying an area of the tissue at risk for disease formation or disease progression includes comparing an HT oxygentation map of a tissue on the subject's foot generated from the collected oxygenation information to an oxygenation map generated from oxygenation information from another foot.

15. The method of claim 1 , wherein:
collecting tissue oxygenation, tissue oxygen extraction, tissue metabolism, or tissue perfusion information of said tissue includes generating a hyperspectral image of the tissue; and
determining a pressure applied to said tissue includes generating a pressure gradient map that indicates pressures applied across the tissue; the method further comprising:
co-registering the pressure gradient map to the hyperspectral image of the tissue.

16. The method of claim 1 , wherein the area of the tissue at risk for disease formation or disease progression is an area of the tissue at risk for ulceration.

17. A method comprising:
(A) determining a physiological state of a tissue of a subject by using a hyperspectral imaging device to collect tissue oxygenation, tissue oxygen extraction, tissue metabolism, or tissue perfusion information of said tissue;
(B) determining a pressure applied to said tissue;
(C) identifying an area of the tissue at risk for disease formation or disease progression based on the physiological state of the tissue or corresponding aspects of the pressure applied to the tissue; and
(D) modifying the pressure applied to the at risk tissue,
wherein identifying an area of the tissue at risk for disease formation or disease progression includes comparing changes in oxygenation levels of the tissue before and after exercise.

18. The method of claim 17 , wherein:
collecting tissue oxygenation, tissue oxygen extraction, tissue metabolism, or tissue perfusion information of said tissue includes generating a hyperspectral image of the tissue; and
determining a pressure applied to said tissue includes generating a pressure gradient map that indicates pressures applied across the tissue; the method further comprising:
co-registering the pressure gradient map to the hyperspectral image of the tissue.

19. The method of claim 17 , wherein the area of the tissue at risk for disease formation or disease progression is an area of the tissue at risk for ulceration.

20. The method of claim 17 , wherein the tissue is located on a toe, a foot, a leg, a finger, a hand, or an arm of the subject.

21. The method of claim 17 , wherein the pressure applied to the tissue comprises pressure exerted on the tissue from a prosthetic device.

22. The method of claim 21 , wherein the prosthetic device is selected from the group consisting of a toe, foot, hand, finger, leg or arm prosthesis.

23. The method of claim 17 , wherein modifying the pressure applied to the at risk tissue comprises altering the structure of a prosthetic device, a compression stocking, a bandage, or a tissue wrap applied to the subject.

24. The method of claim 23 , wherein altering the structure of the prosthetic device comprises adding or removing cushioning material.

25. The method of claim 24 , wherein the adding or removing cushioning prevents ulceration or tissue breakdown attributable to the prosthetic device.

26. The method of claim 23 , wherein modifying the pressure applied to the at risk tissue reduces the risk of tissue ischemia in unbroken skin, formation of an ulcer or wound, formation of a plantar ulcer, venous stasis, venous ulcer disease, or an infection.

27. The method of claim 17 , wherein the determined pressure applied to said tissue is distributed on tissue of a lower extremity of the subject by a device tailored to increase pressure on tissues around areas of venous ulceration.

28. The m

Assignees

• Hypermed Imaging Inc

Inventors

• Freeman Jenny E
• Panasyuk Svetlana
• Hopmeier Michael
• Brand Derek
• Schomacker Kevin

Classifications

• A61B5/447

  specially adapted for aiding the prevention of ulcer or pressure sore development, i.e. before the ulcer or sore has developed · CPC title

• A61B2562/046

  in a matrix array · CPC title

• G01N2021/3144

  for oxymetry · CPC title

• G01N21/359

  using near infrared light · CPC title

• G16H50/20

  for computer-aided diagnosis, e.g. based on medical expert systems · CPC title